CS logo
small CS logo
Kresge Eye Institute

Detroit, Michigan, United States
Medical institution in Detroit, Michigan
4717 St Antoine, Detroit, MI 48201

About Kresge Eye Institute


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Glaukos Corporation
2
Hoffmann-La Roche
2
Kresge Eye Institute
2
ThromboGenics
2
Aldeyra Therapeutics, Inc.
1
Alimera Sciences
1
Eyetech Pharmaceuticals
1
GenVec
1
Hermann Eye Center
1
Jaeb Center for Health Research
1
Total Rows: 16

Clinical Trials at Kresge Eye Institute


During the past decade, Kresge Eye Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100221100000033Started TrialsCompleted Trails201620172018201901234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
2004-05-01
Completed
90
Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)
Completed
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan
2003-09-01
2005-10-01
Completed
200
A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma
2005-06-01
2010-03-01
Completed
240
Age-Related Eye Disease Study 2 (AREDS2)
2006-09-01
2012-10-01
Completed
4,203
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
2004-07-01
2008-10-01
Completed
840
A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
2006-04-19
2022-01-19
Completed
596
Ranibizumab for Neovascularization in Sickle Cell Retinopathy
2010-01-01
2011-06-01
Withdrawn
0

Rows per page:

1–23 of 23

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kresge Eye Institute" #1 sponsor was "Pfizer" with 4 trials, followed by "Glaukos Corporation" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Kresge Eye Institute" with 2 trials sponsored and "ThromboGenics" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kresge Eye Institute" #1 collaborator was "Alcon Research" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator and "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 4Pfizer: 4Glaukos Corporation: 2Glaukos Corporation: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Kresge Eye Institute: 2Kresge Eye Institute: 2ThromboGenics: 2ThromboGenics: 2Aldeyra Therapeutics, Inc.: 1Aldeyra Therapeutics, Inc.: 1Alimera Sciences: 1Alimera Sciences: 1Eyetech Pharmaceuticals: 1Eyetech Pharmaceuticals: 1GenVec: 1GenVec: 1Hermann Eye Center: 1Hermann Eye Center: 1

Created with Highcharts 11.1.0Top CollaboratorsAlcon Research: 1Alcon Research: 1Allergan: 1Allergan: 1Genentech, Inc.: 1Genentech, Inc.: 1National Center forComplementary andIntegrative Health(NCCIH): 1National Center forComplementary andIntegrative Health(NCCIH): 1National Eye Institute (NEI): 1National Eye Institute (NEI): 1National Heart, Lung,and Blood Institute(NHLBI): 1National Heart, Lung,and Blood Institute(NHLBI): 1Office of DietarySupplements (ODS): 1Office of DietarySupplements (ODS): 1Otsuka PharmaceuticalCo., Ltd.: 1Otsuka PharmaceuticalCo., Ltd.: 1Pfizer: 1Pfizer: 1Wayne State University: 1Wayne State University: 1

Clinical Trials Conditions at Kresge Eye Institute


According to Clinical.Site data, the most researched conditions in "Kresge Eye Institute" are "Geographic Atrophy" (3 trials), "Diabetic Macular Edema" (2 trials), "Advanced Malignancies Except Leukemia" (1 trials), "Age Related Macular Degeneration" (1 trials) and "Age-Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Kresge Eye Institute" in a lesser frequency.

Clinical Trials Intervention Types at Kresge Eye Institute


Most popular intervention types in "Kresge Eye Institute" are "Drug" (19 trials), "Other" (3 trials), "Procedure" (3 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lampalizumab" (2 trials), "125 µg Ocriplasmin" (1 trials), "1mg triamcinolone acetonide" (1 trials), "4mg triamcinolone acetonide" (1 trials) and "ACU-4429" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kresge Eye Institute


The vast majority of trials in "Kresge Eye Institute" are 22 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Kresge Eye Institute


Currently, there are NaN active trials in "Kresge Eye Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Kresge Eye Institute, 1 suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Kresge Eye Institute, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Not Applicable: 3Not Applicable: 3Phase 1: 3Phase 1: 3Phase 2: 3Phase 2: 3Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 17Completed: 17Terminated: 4Terminated: 4Suspended: 1Suspended: 1Withdrawn: 1Withdrawn: 1